Founding partners at Harver Group Mr. Koji Masuto and Mr. James Aiguo today announced Harver Group is to hold a public open day in Hong Kong upon the opening of its new office in early 2014.
CHUO-KU, Japan -- According to founder and Director Mr. Koji Masuto, the open day will provide an opportunity for the trading community to gain a working knowledge of the procedures employed by Harver Group in assessing and comparing investment instruments, including pre-IPO’s and trading stocks.
The planned open day will provide a glimpse at behind the scenes in a state of the art equity research house, where 8 of Harver Group’s known analysts will each select one stock from Harver Group’s 2011-2012, 24 month hold selections, and present not only the data that led to the selection of that stock but also the process that facilitated the data collection.
Mr. James Aiguo who co-founded Harver Group in 2003 commented “Representatives of the major trading financial institutions in Hong Kong will be invited to attend our open day next year, when we hope to obtain many new contracts and significantly boost Harver Group’s immediate income from the new branch”
With Harver Group’s Hong Kong branch now scheduled to open in early 2014, the Company is currently in the process of recruiting 80 new stock market analysts, to retain whom it will need to considerably increase its Hong Kong client base. However according to Director Mr. Koji Masuto this will be swiftly realized at the planned open day. “Harver Group can demonstrate that on average our new clients are seeing far greater returns through working with us after taking into account our fees, so I am confident that we will successfully market our services in Hong Kong once we have a local presence. I believe this open day will provide the catalyst required to ensure strong growth for Harver Group’s new opening in 2014.”
Further information pertaining to the venue and registration process for Harver Group’s 2014 open day, will be made available to the public later in the year.
Keywords: Mr Koji Masuto and Mr James Aiguo, harvergroup.com,
By: Harver Group
Article Directory: http://www.articlecatalog.com
Copy and Paste Link Code:
Read other Articles from Harver Group:
- Harver Group Long On Asian Stocks as US Job Market Improves
- Harver Group Delegation to Attend AsFA Annual Meeting
- Harver Group to Recruit 80 Market Analysts for Hong Kong Branch
- Harver Group To Invest In Japan Following Weak Economic Data
- Harver Group Appoints Mr. Stephen Rogers as Executive Director
Article ID 1008334 (Views 964)
Announcement from Our Sponsor
Cancer Drugs like Lenvima (generic version Lenvatinib), Imbruvica (generic version Ibrutinib) now have generic versions at tremendous savings. Brain boosting drugs like Provigil (generic version Modafinil) and Nuvigil (generic version Armodafinil) are also popular.